Christell Helena, Birch Stephen, Bondemark Lars, Horner Keith, Lindh Christina
Faculty of Odontology, Malmö University, Malmö, Sweden.
Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON, Canada.
Eur J Orthod. 2018 Jan 23;40(1):65-73. doi: 10.1093/ejo/cjx039.
Examination with Cone Beam CT (CBCT) is common for localizing maxillary canines with eruption disturbance. The benefits and costs of these examinations are unclear.
To measure: 1. the proportion of orthodontists' treatment decisions that were different based on intraoral and panoramic radiography (M1) compared with CBCT and panoramic radiography (M2); and 2. the costs of producing different treatment plans, regarding patients with maxillary canines with eruption disturbance.
Orthodontists participated in a web-based survey and were randomly assigned to denote treatment decisions and the level of confidence in this decision for four patient cases presented with M1 or M2 at two occasions for the same patient case.
One hundred and twelve orthodontists made 445 assessments based on M1 and M2, respectively. Twenty-four per cent of the treatment decisions were different depending on which method the raters had access to, whereof one case differed significantly from all other cases. The mean total cost per examination was €99.84 using M1 and €134.37 using M2, resulting in an incremental cost per examination of €34.53 for M2.
Benefits in terms of number of different treatment decisions must be considered as an intermediate outcome for the effectiveness of a diagnostic method and should be interpreted with caution.
For the patient cases presented in this study, most treatment decisions were the same irrespective of radiological method. Accordingly, this study does not support routine use of CBCT regarding patients with maxillary canine with eruption disturbance.
锥形束CT(CBCT)检查常用于定位萌出障碍的上颌尖牙。这些检查的益处和成本尚不清楚。
正畸医生参与了一项基于网络的调查,被随机分配,针对同一患者的四个病例,分两次分别根据M1或M2来指定治疗决策以及对该决策的信心水平。
112名正畸医生分别基于M1和M2做出了445次评估。24%的治疗决策因评估者所采用的方法不同而有所差异,其中一个病例与所有其他病例有显著差异。使用M1时每次检查的平均总成本为99.84欧元,使用M2时为134.37欧元,M2每次检查的增量成本为34.53欧元。
不同治疗决策数量方面的益处必须被视为诊断方法有效性的中间结果,且应谨慎解读。
对于本研究中呈现的患者病例,无论采用何种放射学方法,大多数治疗决策都是相同的。因此,本研究不支持对患有上颌尖牙萌出障碍的患者常规使用CBCT。